Defiance ETFs’s CVS Health CVS Stock Holding History

Defiance ETFs’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$539K	Buy	5,142 +949	+23%	+$84.7K	0.01%	272
2026 Q1	$301K	Buy	+4,193	New	+$323K	﹤0.01%	303

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Defiance ETFs's CVS Position: Q2 2026 in Review

Defiance ETFs increased its CVS Health (CVS) stake by 23% in Q2 2026, buying an estimated $84.7K and bringing the position to 5,142 shares worth $539K. The position accounts for 0.01% of the portfolio, ranked #272.

Defiance ETFs first reported a position in CVS in Q1 2026 and has held it in 2 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Defiance ETFs held 5,142 shares of CVS Health worth $539K as of Q2 2026.
Defiance ETFs bought 949 CVS Health shares in Q2 2026, an estimated $84.7K.
CVS Health made up 0.01% of Defiance ETFs's portfolio in Q2 2026, its #272 holding.
Defiance ETFs first reported a position in CVS Health in Q1 2026 and has held it in 2 quarters since.
2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Defiance ETFs's 13F filing for Q2 2026, filed 14 Aug 2026.